189 results on '"Filippa, D."'
Search Results
2. Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation
3. Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial
4. Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification
5. Risk-Adapted Melphalan with Stem Cell Transplant (Sct) and Adjuvant Dexamethasone (Dex) +/- Thalidomide (Thal) Achieves Low Treatmentrelated Mortality and High Hematologic Response Rates
6. Prospective Evaluation of the Utility of the Serum Free Light Chain Assay (FLC), Clonal Ig Vl Gene Identification and Troponin I Levels in a Phase II Trial of Risk-Adapted Intravenous Melphalan with Adjuvant Thalidomide and Dexamethasone for Newly Diagnosed Untreated Patients with Systemic Al Amyloidosis
7. The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
8. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients
9. Systemic AL amyloidosis due to non-Hodgkinʼs lymphoma: an unusual clinicopathologic association
10. Correlation of Biochemical and Immunological Markers with Conventional Morphology and Clinical Features in 120 Patients with Malignant Lymphomas
11. Clinical Significance of TdT, Cell Surface Markers and CFU-C in 297 Patients with Hematopoietic Neoplasias
12. Primary gastric lymphoma: A review of 50 cases
13. Clinical Significance of TdT, Cell Surface Markers and CFU-C in 297 Patients with Hematopoietic Neoplasias
14. ADOPTIVE TRANSFER OF EBV SPECIFIC T-CELLS (EBV-CTL) FOR TREATMENT OF DOCUMENTED EBV LYMPHOMA FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL (HSCT) OR ORGAN TRANSPLANTS (OT): CLINICAL, VIRAL AND IMMUNOLOGIC CORRELATES.
15. Adoptive Transfer Of EBV Specific T-Cells For Treatment Of Primary And Rituxan Resistant EBV Lymphomas Following Allogeneic Stem Cell Transplants (HSCT): Clinical, Viral And Immunologic Corelates
16. Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation
17. Establishment of a Human Cell Line (SKI-DLCL-1) with a t(1;14)(q21;q32) Translocation from the Ascites of a Patient with Diffuse Large Cell Lymphoma
18. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23)
19. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation
20. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia [see comments]
21. Extraneural Cysticercosis Presenting as a Tumor in a Seronegative Patient
22. Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation.
23. research paper Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic association.
24. Large cell non-Hodgkin lymphoma of childhood: Analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center.
25. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.
26. Primary peripheral nodal lymphoma in children.
27. Lymphomas in dogs. A morphologic, immunologic, and clinical study.
28. Primary nasal-paranasal oropharyngeal lymphoma in the pediatric age group.
29. Primary lymphoma of the liver.
30. Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive man.
31. Hodgkin's disease after treatment of non-Hodgkin's lymphoma.
32. Recent results of multimodal therapy of gastric lymphoma.
33. Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients.
34. Primary pulmonary lymphomas. A clinicopathologic analysis of 36 cases.
35. The non-Hodgkin's lymphomas. I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969.
36. Primary gastrointestinal lymphoma: a 30-year review.
37. LIFE STAR saving lives.
38. t(3;22)(q27;q11): a novel translocation associated with diffuse non- Hodgkin's lymphoma [see comments]
39. Immunologic Parameters in Childhood Hodgkin's Disease II T and B Lymphocytes in the Peripheral Blood of Normal Children and in the Spleen and Peripheral Blood of Children with Hodgkin's Disease
40. Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia
41. Primary gastric lymphoma
42. Extensive bone marrow necrosis associated with multiple myeloma.
43. Acquired immune deficiency syndrome-related pulmonary non-Hodgkin lymphoma regressing after zidovudine therapy.
44. Expert second opinion pathology review of lymphoma in the era of the World Health Organization classification
45. Autologous bone marrow transplantation for patients with poor-prognosis lymphoma.
46. BOOK REVIEWS
47. Extramedullary Hematopoiesis Mimicking Metastatic Lung Carcinoma
48. Effect of a mandatory research requirement on categorical resident academic productivity in a university-based general surgery residency.
49. Implementation of an intern boot camp curriculum to address clinical competencies under the new Accreditation Council for Graduate Medical Education supervision requirements and duty hour restrictions.
50. High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.